BOLDERBIO.COM
Bolder BioTechnology | Advanced Protein Engineering| Advanced Protein Engineering
http://www.bolderbio.com/
| Advanced Protein Engineering
http://www.bolderbio.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
4.4 seconds
16x16
32x32
Bolder Bio Technology
Bolder Bio Technology
678 wes●●●●●●● Street
Lou●●●lle , CO, 80027
US
View this contact
Bolder Bio Technology
Cox George
678 wes●●●●●●● Street
Lou●●●lle , CO, 80027
US
View this contact
Concentric Cloud Solutions
Concentric Cloud Solutions
4000 Hig●●●●●●●●rkway SE
Sm●●na , GA, 30082
US
View this contact
BUY YOUR DOMAIN
24
YEARS
10
MONTHS
5
DAYS
MELBOURNE IT, LTD. D/B/A INTERNET NAMES WORLDWIDE
WHOIS : whois.melbourneit.com
REFERRED : http://www.melbourneit.com
PAGES IN
THIS WEBSITE
6
SSL
EXTERNAL LINKS
5
SITE IP
66.226.70.28
LOAD TIME
4.397 sec
SCORE
6.2
Bolder BioTechnology | Advanced Protein Engineering | bolderbio.com Reviews
https://bolderbio.com
| Advanced Protein Engineering
bolderbio.com
Bolder BioTechnology, Inc. Web Site - News
http://www.bolderbio.com/news.html
Manchester, United Kingdom. US Department of Defense to Fund Research at Indiana University and Epistem UK Investigating Treatments for Radiation Sickness. Click here for complete News Release. Bolder BioTechnology Receives Continued NIH Support For Preclinical Development of a Long-Acting Blood Cell Growth Factor to Treat Hematopoietic Complications of Acute Radiation Exposure. Click here for complete News Release. Click here for complete News Release. Click here for complete News Release. Bolder BioTec...
Bolder BioTechnology Receives Two U.S. Patents for Long-Acting GM-CSF Analogs
http://www.bolderbio.com/pr010103.html
Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Company's Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury. This research was supported by grants from the National Institutes of Health to Dr. H. Thomas Lee and to Bolder Biotechnology, Inc. Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create proprietary human protein pharmaceuticals with enhanced therapeutic properties for the treatment of hematopoietic and endocrine ...
Bolder BioTechnology Receives NIH Grant to Develop Second Generation Infection Fighting Protein
http://www.bolderbio.com/pr05292014.html
Bolder BioTechnology Receives Continued NIH Support to Study Effects of Long-Acting Growth Factors for Treating Acute Radiation Syndrome. Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create proprietary human protein pharmaceuticals with enhanced therapeutic properties for the treatment of hematopoietic and endocrine disorders, cancer and infectious diseases. Research described herein has been supported by grants AI084288, AI084301, AI088298 and AI107340 from NIH.
Bolder BioTechnology Receives $1.2 Million NIH Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease
http://www.bolderbio.com/pr091709b.html
Bolder BioTechnology Receives $1.2 Million NIH Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease. The NIH SBIR program is a peer-reviewed grant program that provides research support to small businesses to discover and develop innovative biomedical products for the treatment of serious unmet medical needs. Joe Cox, Ph.D., President (303) 420-4420 (ext.202) - www.bolderbio.com.
Bolder BioTechnology Receives $1.2 Million NIH Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease
http://www.bolderbio.com/pr08182010.html
Bolder BioTechnology Announces $600,000 Grant from NIH to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome. Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create proprietary human protein pharmaceuticals with enhanced therapeutic properties for the treatment of hematopoietic and endocrine disorders, cancer and infectious diseases. Joe Cox, Ph.D., President (303) 420-4420 (ext.202) - www.bolderbio.com.
TOTAL PAGES IN THIS WEBSITE
6
Bolder BioTechnology Receives $1.2 Million NIH Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease
http://www.boulderbio.com/pr110310.html
Bolder BioTechnology Announces $1.2 Million in Qualifying Therapeutic Discovery Project Grants. November 3, 2010 - Bolder BioTechnology, Inc. today announced that it has been awarded a total of $1.2 million in Qualifying Therapeutic Discovery Project Grants. Grants were awarded for qualified investments under the Qualifying Therapeutic Discovery Project Tax Credit Program, which authorized up to $1 billion in tax credits or grants to biopharmaceutical companies with 250 or fewer employees. Bolder BioTech...
Bolder BioTechnology Receives NIH Grant to Develop Second Generation Infection Fighting Protein
http://www.boulderbio.com/pr05292014.html
Bolder BioTechnology Receives Continued NIH Support to Study Effects of Long-Acting Growth Factors for Treating Acute Radiation Syndrome. Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create proprietary human protein pharmaceuticals with enhanced therapeutic properties for the treatment of hematopoietic and endocrine disorders, cancer and infectious diseases. Research described herein has been supported by grants AI084288, AI084301, AI088298 and AI107340 from NIH.
Bolder BioTechnology Receives $1.2 Million NIH Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease
http://www.boulderbio.com/pr08182010.html
Bolder BioTechnology Announces $600,000 Grant from NIH to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome. Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create proprietary human protein pharmaceuticals with enhanced therapeutic properties for the treatment of hematopoietic and endocrine disorders, cancer and infectious diseases. Joe Cox, Ph.D., President (303) 420-4420 (ext.202) - www.bolderbio.com.
Bolder BioTechnology Receives $1.2 Million NIH Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease
http://www.boulderbio.com/pr091709b.html
Bolder BioTechnology Receives $1.2 Million NIH Grant to Continue Development of Long-Acting EPO Analog for Chronic Kidney Disease. The NIH SBIR program is a peer-reviewed grant program that provides research support to small businesses to discover and develop innovative biomedical products for the treatment of serious unmet medical needs. Joe Cox, Ph.D., President (303) 420-4420 (ext.202) - www.bolderbio.com.
TOTAL LINKS TO THIS WEBSITE
5
Home - BOLDER: helping you getting better results
Did you know how to transform your company from good to great? Hal yang paling menentukan keberhasilan atau kegagalan perusahaan adalah manusia. Bukan modal, aset, ataupun situasi pasar, seperti yang diucapkan oleh Jim Collins, penulis buku 'Good to Great' yang menyatakan bahwa,. Masalah utama dalam meningkatkan kinerja perusahaan dari bagus menjadi luar biasa bukanlah di bisnis perusahaan, tetapi di manusianya.". Selalu berupaya untuk memperjelas dan memahami kebutuhan klien. Kami menjadikan BOLDER seba...
大阪で行われるメソセラピーの施術
Http:/ diet.goo.ne.jp/topics/0903 no2/. Http:/ www.amazon.co.jp/6in1-%E3%80%8E%E6%A5%AD%E5%8B%99%E7%94%A8%E3%80%8F%E3%82%AD%E3%83%A3%E3%83%93%E3%83%86%E3%83%BC%E3%82%B7%E3%83%A7%E3%83%B3-%E3%83%A9%E3%82%B8%E3%82%AA%E6%B3%A2-%E8%B6%85%E9%9F%B3%E6%B3%A2-%E9%A1%94%E7%94%A8-%E4%BD%93%E7%94%A8/dp/B00CM5RXKG. Http:/ matome.naver.jp/odai/2138253175430529101.
bolderbikepacking.wordpress.com
Bolder Bikepacking Gear « Rugged lightweight bikepacking gear for racers and adventurers.
Rugged lightweight bikepacking gear for racers and adventurers. Welcome to Bolder Bikepacking Gear. Leave a Reply Cancel reply. Enter your comment here. Fill in your details below or click an icon to log in:. Address never made public). You are commenting using your WordPress.com account. ( Log Out. You are commenting using your Twitter account. ( Log Out. You are commenting using your Facebook account. ( Log Out. You are commenting using your Google account. ( Log Out. Notify me of new comments via email.
bolderbikepackinggear.wordpress.com
Protected Blog › Log in
Https:/ bolderbikepackinggear.wordpress.com/. Is marked private by its owner. If you were invited to view this site, please log in. Below Read more about privacy settings. Larr; Back to WordPress.com.
Bolder Billing Services | Leader in Anesthesia Billing Solutions
FREE PRACTICE PERFORMANCE APPRAISAL. FREE PRACTICE PERFORMANCE APPRAISAL. A Bold new way. Free Practice Performance Appraisal. We leverage our proprietary. We are a leading provider of anesthesia billing solutions nationwide. We give our clients an edge by capturing revenue opportunities and reducing operational costs. We deliver billing solution rooted in compliance and constantly verify that compliance internally and externally. Sarasota, FL 34243.
Bolder BioTechnology | Advanced Protein Engineering
2425 55th Street, Suite 210 Boulder, CO 80301. Maximizing the Power of Proteins to Improve Patients’ Lives. Providing patients with easier to use,. More effective protein therapeutics. We aspire to be a global leader. In the development of cost-effective, easy to use. Protein therapeutics that positively impact patients’ lives. Empowering proteins to better treat diseases. Granulocyte Colony-Stimulating Factor (G-CSF) stimulates production…. Multiple Sclerosis is a chronic central…. The US. governmen...
Bolder BioPATH, Inc. - Preclinical CRO - In Vivo Rodent Models
Toxicology and Pharmacokinetic Studies. Welcome to Bolder BioPATH. Bolder BioPATH, Inc. is a preclinical CRO specializing in In Vivo models of Rheumatoid Arthritis, Osteoarthritis, Inflammatory Bowel Disease as well as other autoimmune and inflammation models, Our goals are to provide preclinical (efficacy and toxicity) data to support advancing proteins and small molecules to IND/NDA stage. Tell Us About Your Project! Get a Quote ». This field is for validation purposes and should be left unchanged.
My Site
This is my site description. A website created by GoDaddy’s Website Builder.
Bolder Business
Price Request - BuyDomains
Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.
BolderBlog.com
Tuesday, 3 February 2015. Matt Cornell Performs The Australian Crawl Classic, 'Reckless' - Plus More. Just before Christmas, we spent a fantastic day at Sydney's Love Hz Studios. Filming some special acoustic performances for Matt Cornell. He was joined by his producer Matt Fell. Plus some very talented friends in Mike Carr. Below are a couple of those performances. Firstly, here is a performance of 'What Brothers Do' which appears on Matt's new self-titled album. Song, 'Reckless.'. Throw down your guns.
